Cement

SPONSORED ADVERTISEMENT

ANAESTHETIC PRACTICE MANAGEMENT

Designed for Anaesthetists by Anaesthetist

Nova streamlines your anaesthetic practice with expert management, billing and financial services – so you can focus on what truly matters.


{}


Bone Cement Implantation Syndrome (BCIS)

Definition

  • Bone Cement Implantation Syndrome (BCIS) is a peri-procedural cardiorespiratory disturbance characterised by any combination of hypoxia (SpO₂ < 94 %), hypotension (fall in systolic arterial pressure > 20 %), unexpected loss of consciousness, or cardiovascular collapse occurring around cementation, prosthesis insertion, joint reduction, or tourniquet release during orthopaedic surgery.
  • Although most frequently associated with cemented hip arthroplasty, similar physiology is described in uncemented and spinal procedures, suggesting a multifactorial aetiology beyond cement alone.

Incidence

(Scoping reviews 2024-25 show stable incidence despite modern techniques.)

  • Cemented hip arthroplasty: 15–47 % overall; severe (Grade 2-3) 4–7 %.
  • Cemented knee arthroplasty: 28–71 %.
  • Shoulder arthroplasty: ~16 %.
  • Uncemented hip arthroplasty: < 22 %, usually Grade 1.

Clinical Grading (Donaldson)

Grade Criteria 30-day mortality
1 SpO₂ < 94 % or SAP ↓ > 20 % Baseline
2 SpO₂ < 88 % or SAP ↓ > 40 % or LOC ↑ 16-fold vs G1
3 Cardiovascular collapse / CPR required up to 88 %

Timing “Danger Windows”

  • Cement pressurisation and stem insertion
  • Joint reduction (intramedullary pressure spike)
  • Tourniquet deflation (knee/shoulder)
  • Reaming of long bones or vertebral bodies

Pathophysiology

  • Embolic Load
    • High intramedullary pressure drives fat, marrow, air, fibrin, platelet aggregates and cement particles into the venous system → RV outflow obstruction and raised pulmonary vascular resistance (PVR).
  • Pulmonary Vasoreactivity
    • Endothelial injury and circulating mediators (thrombin, serotonin, thromboxane A₂, platelet-activating factor, endothelin-1) exacerbate acute pulmonary vasoconstriction, precipitating right-ventricular (RV) failure.
  • Ventriculo-Ventricular Interaction
    • The thin-walled RV dilates against fixed pericardial volume, shifting the interventricular septum leftwards:
      • ↓ LV compliance & preload
      • ↓ Cardiac output
      • Systemic hypotension ± pulseless electrical activity
  • Monomer & Thermal Effects (minor)
    • Circulating methyl-methacrylate (MMA) can cause vasodilation in vitro, and exothermic polymerisation injures marrow endothelium, but contemporary evidence suggests these are secondary contributors.

Risk Factors

Patient Surgical Anaesthetic
Age > 75 yr Cemented long-stem or revision arthroplasty GA with volatile agents ± N₂O
ASA III-IV Pathological/inter-trochanteric fracture Hypovolaemia
Pre-existing pulmonary hypertension or RV dysfunction High-viscosity cement, poor lavage Inadequate oxygenation
COPD, active malignancy (esp. lung mets) Inadequate venting/cement restrictor Diuretic or warfarin therapy
Chronic renal failure, frailty Bilateral or simultaneous procedures Lack of advanced haemodynamic monitoring

Risk-Reduction Strategies

Surgical

  • Pulsatile lavage & canal drying before cementation
  • Intramedullary venting or distal plug to limit pressure
  • Retrograde, low-viscosity vacuum-mixed cement, small boluses
  • Cement gun with pressure-relief holes; pause ventilation during pressurisation
  • Consider cementless or short-stem prosthesis in extreme risk

Anaesthetic

  1. Preparation
    • Optimise volume status; avoid hypovolaemia
    • Pre-emptive arterial line ± cardiac output monitor (e.g. oesophageal Doppler/TEE) in ASA ≥ III
  2. During High-Risk Steps
    • FiO₂ 0.8-1.0; turn off N₂O
    • Communicate “cement time” countdown with theatre team
    • Low-dose vasopressor (norepinephrine 0.02-0.05 µg kg⁻¹ min⁻¹) running before cement insertion in frail patients
  3. Early Warning
    • Sudden ETCO₂ fall, SpO₂ drop, or RV dilation on echo precede haemodynamic collapse
  4. Post-cement
    • Maintain vigilance for 15 min; continue supplemental O₂ into recovery

Composition of Polymethyl-Methacrylate (PMMA) Cement

Component Function
Pre-polymerised PMMA powder (≈ 90 %) Matrix
Dibenzoyl-peroxide Polymerisation initiator
Liquid MMA monomer + N,N-dimethyl-p-toluidine Activator & carrier
Radiopacifier 10 % (barium sulphate / zirconium dioxide) Imaging
Optional antibiotics (gentamicin, tobramycin, clindamycin ≤ 1 g per 40 g cement) Local prophylaxis

Antibiotic loading may weaken cement, encourage resistance, and cause nephrotoxicity in susceptible patients.

Management Algorithm

  1. Suspect BCIS → Announce & stop further surgical pressurisation
  2. 100 % O₂, manual ventilation; increase PEEP cautiously
  3. Haemodynamics
    • Restore preload (crystalloid/colloid bolus)
    • Vasopressor of choice: norepinephrine (α₁ ± β) or phenylephrine if tachycardic
    • Add inotrope (dobutamine, epinephrine) if RV failure dominates (T-echo helpful)
  4. Advanced Support
    • Pulmonary vasodilators (inhaled nitric oxide or prostacyclin) for refractory PVR
    • Mechanical circulatory/respiratory support (VA-ECMO) if collapse persist
  5. Post-event
    • ICU admission; monitor troponin, renal function, coagulation
    • Consider postoperative CT pulmonary angiography if diagnostic doubt

Links



References:

  1. Donaldson, A., Thomson, H., Harper, N., & Kenny, N. W. (2009). Bone cement implantation syndrome. British Journal of Anaesthesia, 102(1), 12-22. https://doi.org/10.1093/bja/aen328
  2. Association of Anaesthetists. Management of hip fractures 2020–includes updated guidance on BCIS risk mitigation. https://anaesthetists.org
  3. Bone Cement Implantation Syndrome: a scoping review. Br J Anaesth 2025;135:1-12. PubMed
  4. Barakat N, Browne JA. Is BCIS actually caused by cement? Systematic review using Bradford-Hill criteria. J Arthroplasty 2025;40(8S1):S353-S359.
  5. Kaufmann KB et al. Goal-directed therapy and BCIS in cemented hip arthroplasty: RCT. BMC Anesthesiol 2018;18:63.
  6. Rass J et al. Bone cement and its anaesthetic complications: narrative review. J Clin Med 2023;12:2105.
  7. Study of the cement implantation syndrome. Medicine (Baltimore) 2024;103:e35127.
  8. National Patient Safety Team. BCIS case review and safety alert. NHS England 2025.
  9. FRCA Mind Maps. (2024). Retrieved June 5, 2024, from https://www.frcamindmaps.org/
  10. Clarkson AJ et al. Principles of cemented stem implantation in hip arthroplasty–state-of-the-art technique. EFORT Open Rev 2024;9:1-13.
  11. Donaldson AJ et al. Bone cement implantation syndrome. Br J Anaesth 2009;102:12-22.
  12. Association of Anaesthetists, British Orthopaedic Association, British Geriatric Society. Safety guideline: reducing the risk from cemented hemiarthroplasty (reaffirmed 2021). Anaesthesia 2015;70:623-626 (current at time of writing).
  13. Anesthesia Considerations. (2024). Retrieved June 5, 2024, from https://www.anesthesiaconsiderations.com/

Summaries:
Bone cement implantation syndrome



Copyright
© 2025 Francois Uys. All Rights Reserved.

id: “ea296baf-4e67-4f64-97be-43509d8c61bd”

Please log in to view your notes.

Related article